Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Todd Murphy

Sports Medicine Port Huron, MI Medical Doctor

NPI 1346252095 CMS profile 1056133

940 River Centre Dr, Port Huron, MI 48060

Open in the dashboard

General payments

$3,926

36 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Todd Murphy of Port Huron, MI is reported in the CMS Open Payments database as having received $3,926 across 36 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 38th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,279 7
2024 General $18 1
2023 General $17 1
2022 General $135 6
2021 General $2,459 20
2020 General $19 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Todd Murphy
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Todd Murphy were reported at $1,279. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Todd Murphy Sports Medicine median Middle half National median
2019 $0 $1,176 $199–$4,249 $163
2020 $19 $708 $96–$2,890 $114
2021 $2,459 $1,213 $152–$3,994 $132
2022 $135 $1,230 $159–$3,998 $149
2023 $17 $584 $146–$2,836 $160
2024 $18 $628 $163–$3,168 $164
2025 $1,279 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Arthrex, Inc. $2,038 14 payments
  2. Zimmer Biomet Holdings, Inc. $1,279 7 payments
  3. Pinnacle, Inc $389 4 payments
  4. Stryker Corporation $122 5 payments
  5. Smith+Nephew, Inc. $48 3 payments
  6. Boston Scientific Corporation $19 1 payment
  7. Bioventus LLC $18 1 payment
  8. DePuy Synthes Sales Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $1,427 7 payments
  2. Education $1,350 2 payments
  3. Food and Beverage $1,149 27 payments
Products named General payments · program years 2020–2025
  1. Comprehensive Shoulder System $789 3 payments
  2. ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER ECLIPSE $124 1 payment
  3. MAKO $105 4 payments
  4. Juggerknotless Soft Anchor $104 2 payments
  5. Tapestry $104 2 payments
  6. Quatro GL $104 2 payments
  7. Osseofit $99 1 payment
  8. JOURNEY II $20 1 payment
  9. SPECTRA WAVEWRITER $19 1 payment
  10. EXOGEN ULTRASOUND BONE HEALING SYSTEM $18 1 payment
  11. Other $71 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

388

Median for Orthopedic Surgery: 203

Drug cost

$1,510

Median for Orthopedic Surgery: $1,433

Branded share of claims

39.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 131 $874
Mupirocin Generic 30 $197
Acetaminophen-Codeine Acetaminophen With Codeine Brand 22 $189
Amoxicillin Generic 140 $127
Tramadol Hcl Generic 32 $75
Prednisone Generic 11 $26
Clindamycin Hcl Generic 22 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$128,884

Of which drugs: $4,421

Medicare patients

362

Average age 74

Services billed

4,806

222 women, 140 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 32%
Diabetes 28%
Chronic kidney disease 22%
COPD 21%
Depression 21%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 140 1,308 $952

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record